Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain.
Elagolix (ELA) 200 mg twice daily is an oral treatment approved for moderate-to-severe endometriosis-associated pain. However, the clinical use of ELA is limited by potential hypoestrogenic effects, including the loss …
Severe endometriosis complicated by deep vein thrombosis and pulmonary embolism in the absence of hormone therapy: A case report and literature review.
To report a rare case of severe endometriosis complicated by deep vein thrombosis (DVT) and pulmonary embolism (PE) without hormone exposure, and review similar cases in the literature.
Impact of a National Public Health Plan on the time frame for moderate and severe endometriosis diagnosis.
to study the time from symptom onset to the diagnosis of moderate and severe endometriosis and to compare this delay before and after the implementation of a National Endometriosis Public …